Scenarios that move RLMD

Relmada Therapeutics, Inc. - Common Stock

Scenarios that move RLMD: 1 analysis, 1 positive, 0 negative.

  1. · Xenon files epilepsy NDA as depression study setback weighs — ▲ · impact +40 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing